UBS said the outlook for MCX has improved on the back of positive regulatory developments, resilient trading volumes and continued support from elevated commodity price volatility.
UBS said the outlook for MCX has improved on the back of positive regulatory developments, resilient trading volumes and continued support from elevated commodity price volatility.